The global market for Non-Alcoholic Steatohepatitis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Nonalcoholic steatohepatitis (NASH) is inflammation of your liver caused by excess fat cells in it (fatty liver disease). Chronic inflammation causes progressive liver damage. NASH resembles hepatitis caused by alcohol use, but it stems from something else.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-Alcoholic Steatohepatitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Alcoholic Steatohepatitis Treatment.

The Non-Alcoholic Steatohepatitis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Alcoholic Steatohepatitis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Alcoholic Steatohepatitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Alcoholic Steatohepatitis Treatment Market Report

Report Metric	Details
Report Name	Non-Alcoholic Steatohepatitis Treatment Market
CAGR	5%
Segment by Type	Vitamin E and Pioglitazone Obeticholic Acid (OCA) Lanifibranor Semaglutide Resmetirom Aramchol Cenicriviroc Others
Segment by Application	Hospital Pharmacies Retail & Specialty Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Intercept Pharmaceuticals, Galmed Pharmaceuticals, Inventiva Pharma, AbbVie Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals, NGM Biopharmaceuticals Inc., Novo Nordisk A/S, Bristol Myers Squibb, Gilead Sciences Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Alcoholic Steatohepatitis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-Alcoholic Steatohepatitis Treatment Market report?

Ans: The main players in the Non-Alcoholic Steatohepatitis Treatment Market are Intercept Pharmaceuticals, Galmed Pharmaceuticals, Inventiva Pharma, AbbVie Inc., Galectin Therapeutics Inc., Madrigal Pharmaceuticals, NGM Biopharmaceuticals Inc., Novo Nordisk A/S, Bristol Myers Squibb, Gilead Sciences Inc.

What are the Application segmentation covered in the Non-Alcoholic Steatohepatitis Treatment Market report?

Ans: The Applications covered in the Non-Alcoholic Steatohepatitis Treatment Market report are Hospital Pharmacies, Retail & Specialty Pharmacies, Others

What are the Type segmentation covered in the Non-Alcoholic Steatohepatitis Treatment Market report?

Ans: The Types covered in the Non-Alcoholic Steatohepatitis Treatment Market report are Vitamin E and Pioglitazone, Obeticholic Acid (OCA), Lanifibranor, Semaglutide, Resmetirom, Aramchol, Cenicriviroc, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Vitamin E and Pioglitazone

1.2.3 Obeticholic Acid (OCA)

1.2.4 Lanifibranor

1.2.5 Semaglutide

1.2.6 Resmetirom

1.2.7 Aramchol

1.2.8 Cenicriviroc

1.2.9 Others

1.3 Market by Application

1.3.1 Global Non-Alcoholic Steatohepatitis Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail & Specialty Pharmacies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Perspective (2020-2031)

2.2 Global Non-Alcoholic Steatohepatitis Treatment Growth Trends by Region

2.2.1 Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Region (2020-2025)

2.2.3 Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2026-2031)

2.3 Non-Alcoholic Steatohepatitis Treatment Market Dynamics

2.3.1 Non-Alcoholic Steatohepatitis Treatment Industry Trends

2.3.2 Non-Alcoholic Steatohepatitis Treatment Market Drivers

2.3.3 Non-Alcoholic Steatohepatitis Treatment Market Challenges

2.3.4 Non-Alcoholic Steatohepatitis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Alcoholic Steatohepatitis Treatment Players by Revenue

3.1.1 Global Top Non-Alcoholic Steatohepatitis Treatment Players by Revenue (2020-2025)

3.1.2 Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Non-Alcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-Alcoholic Steatohepatitis Treatment Revenue

3.4 Global Non-Alcoholic Steatohepatitis Treatment Market Concentration Ratio

3.4.1 Global Non-Alcoholic Steatohepatitis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Alcoholic Steatohepatitis Treatment Revenue in 2024

3.5 Global Key Players of Non-Alcoholic Steatohepatitis Treatment Head office and Area Served

3.6 Global Key Players of Non-Alcoholic Steatohepatitis Treatment, Product and Application

3.7 Global Key Players of Non-Alcoholic Steatohepatitis Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Alcoholic Steatohepatitis Treatment Breakdown Data by Type

4.1 Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Type (2020-2025)

4.2 Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2026-2031)

5 Non-Alcoholic Steatohepatitis Treatment Breakdown Data by Application

5.1 Global Non-Alcoholic Steatohepatitis Treatment Historic Market Size by Application (2020-2025)

5.2 Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-Alcoholic Steatohepatitis Treatment Market Size (2020-2031)

6.2 North America Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025)

6.4 North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Alcoholic Steatohepatitis Treatment Market Size (2020-2031)

7.2 Europe Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025)

7.4 Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size (2020-2031)

8.2 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size (2020-2031)

9.2 Latin America Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025)

9.4 Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size (2020-2031)

10.2 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Intercept Pharmaceuticals

11.1.1 Intercept Pharmaceuticals Company Details

11.1.2 Intercept Pharmaceuticals Business Overview

11.1.3 Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction

11.1.4 Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.1.5 Intercept Pharmaceuticals Recent Development

11.2 Galmed Pharmaceuticals

11.2.1 Galmed Pharmaceuticals Company Details

11.2.2 Galmed Pharmaceuticals Business Overview

11.2.3 Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction

11.2.4 Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.2.5 Galmed Pharmaceuticals Recent Development

11.3 Inventiva Pharma

11.3.1 Inventiva Pharma Company Details

11.3.2 Inventiva Pharma Business Overview

11.3.3 Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Introduction

11.3.4 Inventiva Pharma Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.3.5 Inventiva Pharma Recent Development

11.4 AbbVie Inc.

11.4.1 AbbVie Inc. Company Details

11.4.2 AbbVie Inc. Business Overview

11.4.3 AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Introduction

11.4.4 AbbVie Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.4.5 AbbVie Inc. Recent Development

11.5 Galectin Therapeutics Inc.

11.5.1 Galectin Therapeutics Inc. Company Details

11.5.2 Galectin Therapeutics Inc. Business Overview

11.5.3 Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Introduction

11.5.4 Galectin Therapeutics Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.5.5 Galectin Therapeutics Inc. Recent Development

11.6 Madrigal Pharmaceuticals

11.6.1 Madrigal Pharmaceuticals Company Details

11.6.2 Madrigal Pharmaceuticals Business Overview

11.6.3 Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Introduction

11.6.4 Madrigal Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.6.5 Madrigal Pharmaceuticals Recent Development

11.7 NGM Biopharmaceuticals Inc.

11.7.1 NGM Biopharmaceuticals Inc. Company Details

11.7.2 NGM Biopharmaceuticals Inc. Business Overview

11.7.3 NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Introduction

11.7.4 NGM Biopharmaceuticals Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.7.5 NGM Biopharmaceuticals Inc. Recent Development

11.8 Novo Nordisk A/S

11.8.1 Novo Nordisk A/S Company Details

11.8.2 Novo Nordisk A/S Business Overview

11.8.3 Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Introduction

11.8.4 Novo Nordisk A/S Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.8.5 Novo Nordisk A/S Recent Development

11.9 Bristol Myers Squibb

11.9.1 Bristol Myers Squibb Company Details

11.9.2 Bristol Myers Squibb Business Overview

11.9.3 Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Introduction

11.9.4 Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.9.5 Bristol Myers Squibb Recent Development

11.10 Gilead Sciences Inc.

11.10.1 Gilead Sciences Inc. Company Details

11.10.2 Gilead Sciences Inc. Business Overview

11.10.3 Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Introduction

11.10.4 Gilead Sciences Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

11.10.5 Gilead Sciences Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Madrigal Pharmaceuticals

Bristol–Myers Squibb

Inventiva Pharma

Intercept Pharmaceuticals

AbbVie

Galmed Pharmaceuticals

Galectin Therapeutics Inc

NGM Biopharmaceuticals, Inc.

Novo Nordisk A S

Gilead Sciences Inc

List of Tables

Table 1. Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Vitamin E and Pioglitazone

Table 3. Key Players of Obeticholic Acid (OCA)

Table 4. Key Players of Lanifibranor

Table 5. Key Players of Semaglutide

Table 6. Key Players of Resmetirom

Table 7. Key Players of Aramchol

Table 8. Key Players of Cenicriviroc

Table 9. Global Non-Alcoholic Steatohepatitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2020-2025)

Table 13. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2026-2031)

Table 15. Non-Alcoholic Steatohepatitis Treatment Market Trends

Table 16. Non-Alcoholic Steatohepatitis Treatment Market Drivers

Table 17. Non-Alcoholic Steatohepatitis Treatment Market Challenges

Table 18. Non-Alcoholic Steatohepatitis Treatment Market Restraints

Table 19. Global Non-Alcoholic Steatohepatitis Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Players (2020-2025)

Table 21. Global Top Non-Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Treatment as of 2024)

Table 22. Ranking of Global Top Non-Alcoholic Steatohepatitis Treatment Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Non-Alcoholic Steatohepatitis Treatment, Headquarters and Area Served

Table 25. Global Key Players of Non-Alcoholic Steatohepatitis Treatment, Product and Application

Table 26. Global Key Players of Non-Alcoholic Steatohepatitis Treatment, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2020-2025)

Table 30. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Type (2026-2031)

Table 32. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2020-2025)

Table 34. Global Non-Alcoholic Steatohepatitis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Non-Alcoholic Steatohepatitis Treatment Revenue Market Share by Application (2026-2031)

Table 36. North America Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 51. Intercept Pharmaceuticals Company Details

Table 52. Intercept Pharmaceuticals Business Overview

Table 53. Intercept Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product

Table 54. Intercept Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 55. Intercept Pharmaceuticals Recent Development

Table 56. Galmed Pharmaceuticals Company Details

Table 57. Galmed Pharmaceuticals Business Overview

Table 58. Galmed Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product

Table 59. Galmed Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 60. Galmed Pharmaceuticals Recent Development

Table 61. Inventiva Pharma Company Details

Table 62. Inventiva Pharma Business Overview

Table 63. Inventiva Pharma Non-Alcoholic Steatohepatitis Treatment Product

Table 64. Inventiva Pharma Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 65. Inventiva Pharma Recent Development

Table 66. AbbVie Inc. Company Details

Table 67. AbbVie Inc. Business Overview

Table 68. AbbVie Inc. Non-Alcoholic Steatohepatitis Treatment Product

Table 69. AbbVie Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 70. AbbVie Inc. Recent Development

Table 71. Galectin Therapeutics Inc. Company Details

Table 72. Galectin Therapeutics Inc. Business Overview

Table 73. Galectin Therapeutics Inc. Non-Alcoholic Steatohepatitis Treatment Product

Table 74. Galectin Therapeutics Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 75. Galectin Therapeutics Inc. Recent Development

Table 76. Madrigal Pharmaceuticals Company Details

Table 77. Madrigal Pharmaceuticals Business Overview

Table 78. Madrigal Pharmaceuticals Non-Alcoholic Steatohepatitis Treatment Product

Table 79. Madrigal Pharmaceuticals Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 80. Madrigal Pharmaceuticals Recent Development

Table 81. NGM Biopharmaceuticals Inc. Company Details

Table 82. NGM Biopharmaceuticals Inc. Business Overview

Table 83. NGM Biopharmaceuticals Inc. Non-Alcoholic Steatohepatitis Treatment Product

Table 84. NGM Biopharmaceuticals Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 85. NGM Biopharmaceuticals Inc. Recent Development

Table 86. Novo Nordisk A/S Company Details

Table 87. Novo Nordisk A/S Business Overview

Table 88. Novo Nordisk A/S Non-Alcoholic Steatohepatitis Treatment Product

Table 89. Novo Nordisk A/S Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 90. Novo Nordisk A/S Recent Development

Table 91. Bristol Myers Squibb Company Details

Table 92. Bristol Myers Squibb Business Overview

Table 93. Bristol Myers Squibb Non-Alcoholic Steatohepatitis Treatment Product

Table 94. Bristol Myers Squibb Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 95. Bristol Myers Squibb Recent Development

Table 96. Gilead Sciences Inc. Company Details

Table 97. Gilead Sciences Inc. Business Overview

Table 98. Gilead Sciences Inc. Non-Alcoholic Steatohepatitis Treatment Product

Table 99. Gilead Sciences Inc. Revenue in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025) & (US$ Million)

Table 100. Gilead Sciences Inc. Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Non-Alcoholic Steatohepatitis Treatment Picture

Figure 2. Global Non-Alcoholic Steatohepatitis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Type: 2024 VS 2031

Figure 4. Vitamin E and Pioglitazone Features

Figure 5. Obeticholic Acid (OCA) Features

Figure 6. Lanifibranor Features

Figure 7. Semaglutide Features

Figure 8. Resmetirom Features

Figure 9. Aramchol Features

Figure 10. Cenicriviroc Features

Figure 11. Others Features

Figure 12. Global Non-Alcoholic Steatohepatitis Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Application: 2024 VS 2031

Figure 14. Hospital Pharmacies Case Studies

Figure 15. Retail & Specialty Pharmacies Case Studies

Figure 16. Others Case Studies

Figure 17. Non-Alcoholic Steatohepatitis Treatment Report Years Considered

Figure 18. Global Non-Alcoholic Steatohepatitis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Non-Alcoholic Steatohepatitis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Region: 2024 VS 2031

Figure 21. Global Non-Alcoholic Steatohepatitis Treatment Market Share by Players in 2024

Figure 22. Global Top Non-Alcoholic Steatohepatitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Alcoholic Steatohepatitis Treatment as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Non-Alcoholic Steatohepatitis Treatment Revenue in 2024

Figure 24. North America Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2020-2031)

Figure 26. United States Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2020-2031)

Figure 30. Germany Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Non-Alcoholic Steatohepatitis Treatment Market Share by Region (2020-2031)

Figure 38. China Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2020-2031)

Figure 46. Mexico Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Non-Alcoholic Steatohepatitis Treatment Market Share by Country (2020-2031)

Figure 50. Turkey Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Non-Alcoholic Steatohepatitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Intercept Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 54. Galmed Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 55. Inventiva Pharma Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 56. AbbVie Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 57. Galectin Therapeutics Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 58. Madrigal Pharmaceuticals Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 59. NGM Biopharmaceuticals Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 60. Novo Nordisk A/S Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 61. Bristol Myers Squibb Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 62. Gilead Sciences Inc. Revenue Growth Rate in Non-Alcoholic Steatohepatitis Treatment Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-2316

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Bilirubin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-35U2436

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Intracardiac Echocardiography Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7J13314

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global End Stage Renal Disease Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2F6212

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Non-Alcoholic Steatohepatitis Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-19S13424

Global Non-Alcoholic Steatohepatitis Treatment Market Research Report 2025

FEATURED COMPANIES

Non-Alcoholic Steatohepatitis Treatment Market Size

Non-Alcoholic Steatohepatitis Treatment Market

Scope of Non-Alcoholic Steatohepatitis Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Non-Alcoholic Steatohepatitis Treatment Market report?

What are the Application segmentation covered in the Non-Alcoholic Steatohepatitis Treatment Market report?

What are the Type segmentation covered in the Non-Alcoholic Steatohepatitis Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS

$8000

Enterprise User

$8000

Enterprise User

$5800

Enterprise User

$5800

Enterprise User